Quantitative tissue maps enabling improved tissue characterization.
Images courtesy: Prof. Siegfried Trattnig, High Field Center, Department for Biomedical Imaging and Image guided Therapy, Medical University of Vienna
Qualitative evaluation of MR images can be inconsistent and may leave many questions:
- Hyperintense lesion observed. Indication of disease?
- Grade? Infiltration into surrounding tissue?
MR Fingerprinting facilitates decision making based on digital tissue data. Dedicated MR Fingerprinting acquisition for rapid and robust quantitative T1 and T2 tissue maps of the brain.
Quantification of tissue properties enable robust, reproducible, results - inter-scanner, and in-vivo - for precision medicine.2
- MAGNETOM Prisma
- MAGNETOM Prismafit
- MAGNETOM Skyra
- MAGNETOM Vida3
- MAGNETOM Vida Fit4
Minimum Software Version
syngo MR XA20
syngo MR XA50A (For Vida Fit)
Note: Additional technical pre-requisites may apply. Upon receiving
your request, your local Siemens representative will clarify whether
your system meets the requirements.
syngo MR XA30 and its features are not commercially available in some countries. Due to regulatory reasons their future availability cannot be guaranteed. Please contact your local Siemens organization for further details.
MRF is not for sale in the U.S. Its future availability cannot be guaranteed.
Data on file. Results may vary
MR Fingerprinting for MAGNETOM Vida is pending 510(k) clearance, and is not yet commercially available in the United States. Its future availability cannot be guaranteed.
MR Fingerprinting for MAGNETOM Vida Fit is still under development and not commercially available yet. Its future availability cannot be ensured.